summary: Statins have been used to reduce cholesterol levels in the general population and have recently also been shown to have anti-inflammatory properties. However, despite this anti-inflammatory effect, it had been suggested in previous studies that people with MS who were taking statins could have a higher risk of developing new MS lesions and relapses. Nevertheless, in this study the authors have demonstrated that treatment with statins in people receiving interferon beta is not causing a reduction of the therapeutic effect of the interferon.

authors: Rudick RA, Pace A, Rani MR, Hyde R, Panzara M, Appachi S, Shrock J, Maurer SL, Calabresi PA, Confavreux C, Galetta SL, Lublin FD, Radue EW, Ransohoff RM

source: Neurology. 2009 Jun 9;72(23):1989-93

weblink: click here

category: Clinical Trials and Therapeutics

related research news: click here

glossary: